Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07685756Active, not recruiting
Trial of misoprostol in cervical ripening (CR) (2 arms), sponsored by Ahmad Hudda. Primary endpoint: Rate of instrumental delivery and cesarean section at 12 months. Started May 2026; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07685756.